Delivery Order SPE2DB22D2206-SPE2DB26FDT03
- Not listed
- The Defense Logistics Agency awarded a $23,841.49 delivery order to AmerisourceBergen Drug Corp for PRIORIX vials, a measles, mumps, rubella, and varicella vaccine product. The order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed-price procurement with no set-aside designation, meaning the contract was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,755.30 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Priorix vials, a measles, mumps, and rubella vaccine product. This firm fixed-price contract, with a completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $2,928.92 delivery order to AmerisourceBergen Drug Corp for PRIORIX vials, a measles, mumps, and rubella vaccine product. The award was competitively procured without set-aside provisions and carries an ultimate completion date of September 3, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania, under a firm fixed-price contract structure. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $49,506.00 to supply Priorix vials, a measles-rubella-varicella vaccine product. This firm fixed-price, competitively awarded delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents part of the company's ongoing pharmaceutical and medical supply support to...
- The Defense Logistics Agency (DLA) awarded a $14,845.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of June 10, 2025. This is a non-set-aside competitive award executed on June 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency (DLA) awarded a $80,289.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials. This competitively awarded, non-set-aside contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella (MMR) vaccine used across military and federal healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Priorix vials, valued at $35,329.70. This firm fixed-price delivery order, which is expected to be completed by July 23, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $27,668.94 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Priorix vials with a completion deadline of August 4, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $97,082 delivery order to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of October 21, 2025. This competitive, firm fixed-price contract was issued without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella (MMR) combination vaccine used by military and federal healthcare systems to support immunization requirements across the...
- The Defense Logistics Agency awarded a $1,514.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at the contractor's location in Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDT03Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,191.75 to AmerisourceBergen Drug Corp for PRIORIX vials, a measles, mumps, and rubella (MMR) vaccine. Issued on October 22, 2025, with an ultimate completion date of October 23, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999.999 billion prime contract vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, has demonstrated substantial capability in fulfilling DLA medical procurement requirements through open competition. The company's role as a pharmaceutical prime vendor enables it to supply a broad spectrum of pharmaceutical products, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular vaccine delivery supports the military health system's medical readiness and troop health protection initiatives within DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/22/25 |